Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancerAna Valdehíta, Marı́a J. Carmena, Eva Vacas et al.|Peptides|2010Cited by 54
Multifunctional role of VIP in prostate cancer progression in a xenograft model: Suppression by curcumin and COX-2 inhibitor NS-398Ana B. Fernández‐Martínez, Juan Carlos Prieto, Ana M. Bajo et al.|Peptides|2009Cited by 23
Growth hormone-releasing hormone antagonists abolish the transactivation of human epidermal growth factor receptors in advanced prostate cancer modelsLaura Muñoz‐Moreno, Ana M. Bajo, M. Isabel Arenas et al.|Investigational New Drugs|2014Cited by 18
Anti-proliferative and pro-apoptotic effects of GHRH antagonists in prostate cancerLaura Muñoz‐Moreno, Ana M. Bajo, M. Isabel Arenas et al.|Oncotarget|2016Cited by 14
Antagonist of Growth Hormone-Releasing Hormone Receptor MIA-690 Suppresses the Growth of Androgen-Independent Prostate CancersLaura Muñoz‐Moreno, Ana M. Bajo, Juan Carlos Prieto et al.|International Journal of Molecular Sciences|2024Cited by 2